Location History:
- Incheon, KR (2016 - 2017)
- Seoul, KR (2020)
Company Filing History:
2 out of 1,348 
1 out of 4 
1 out of 1 Years Active: 2016-2020
Title: Han Na Kang: Innovator in Pharmaceutical Composition
Introduction
Han Na Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of non-small cell lung cancer. With a total of 3 patents, his work focuses on innovative drug compositions and methods that enhance therapeutic efficacy.
Latest Patents
One of Han Na Kang's latest patents involves the use of a statin-based drug for the treatment of EML4-ALK-positive non-small cell lung cancer that is progressing on an ALK inhibitor. This patent provides a pharmaceutical composition that exhibits therapeutic efficacy against this specific type of cancer, which has acquired resistance to standard treatments. Additionally, it outlines a method for selecting appropriate drugs for patients suffering from this condition.
Another notable patent by Kang is a pharmaceutical composition that increases solubility by utilizing saccharin. This invention includes an ionic liquid composed of a triptan compound and saccharin, which significantly enhances the solubility of the triptan compound. This advancement allows for a rapid and high dissolution of the compound when preparing pharmaceutical compositions, while minimizing the need for large amounts of organic and acidic solvents.
Career Highlights
Han Na Kang has worked with esteemed institutions such as Yonsei University and Huons Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.
Collaborations
Throughout his career, Kang has collaborated with notable colleagues, including Sung Joon Wang and Kwang Ho Cha. These partnerships have further enriched his research and innovation in the pharmaceutical field.
Conclusion
Han Na Kang is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact cancer treatment. His innovative approaches and collaborations highlight his commitment to advancing medical science.